BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 26
• 27
• 28
• 29
• 30

• LABSCO Implements Leading-Edge Technology to Support Growth and Seize Opportunities in the Clinical Laboratory Market

  November 6, 2012

   · 

  4 min read
• Drug Development

  Merck & Co., Inc. Will Initiate Interferon-Free Phase II Clinical Trials for MK-5172, an Investigational, Once-Daily, Oral Treatment for Chronic Hepatitis C Virus

  November 6, 2012

   · 

  4 min read
• Biotech Beach

  Insiders Commit $50 Million to Ambit Biosciences

  November 6, 2012

   · 

  2 min read
• Wright Medical Group, Inc. Will Split in Two U.S. Divisions

  November 6, 2012

   · 

  1 min read
• FDA

  Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant

  November 6, 2012

   · 

  5 min read
• Business

  Cedarburg Hauser Promotes John K. Lynch to Chief Scientific Officer

  November 6, 2012

   · 

  1 min read
• Drug Development

  OncoGenex Pharmaceuticals Inc. Announces Completion of Patient Enrollment in Custirsen Phase 3 “SYNERGY” Study

  November 6, 2012

   · 

  4 min read
• BioMidwest

  Perrigo Company Announces Quarterly Dividend

  November 6, 2012

   · 

  1 min read
• Drug Development

  Lexicon Pharmaceuticals, Inc. Release: LX4211 Phase 2b Results Presented at American Heart Association Annual Conference

  November 6, 2012

   · 

  5 min read
• Biotech Bay

  Varian Medical Systems Management to Present at Jefferies and Co. 2012 Global Healthcare Conference

  November 6, 2012

   · 

  1 min read